0001209191-19-038450.txt : 20190621
0001209191-19-038450.hdr.sgml : 20190621
20190621160335
ACCESSION NUMBER: 0001209191-19-038450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190619
FILED AS OF DATE: 20190621
DATE AS OF CHANGE: 20190621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Thomas Patrick
CENTRAL INDEX KEY: 0001410514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 19911527
MAIL ADDRESS:
STREET 1: 60 WESTVIEW STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 500 TOTTEN POND ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-19
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001410514
Kelly Thomas Patrick
C/O DECIPHERA PHARMACEUTICALS, INC.
500 TOTTEN POND ROAD
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
Common Stock
2019-06-19
4
M
0
177
1.89
A
177
D
Common Stock
2019-06-19
4
S
0
177
25.00
D
0
D
Stock Option (Right to Buy)
1.89
2019-06-19
4
M
0
177
0.00
D
2025-12-17
Common Stock
177
149258
D
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal installments over a 4-year period following the vesting commencement date of 2/23/2015, subject to continued service through such dates.
/s/ Thomas P. Kelly
2019-06-21